Atlas Trials

High Grade Ovarian Serous Adenocarcinoma

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Grade Ovarian Serous Adenocarcinoma

RecordFirmDate
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients (NCT05114421)M.D. Anderson Cancer Center2021-11-09
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer (NCT04794322)Massachusetts General Hospital2020-04-13
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery (NCT03943173)M.D. Anderson Cancer Center2019-06-07
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer (NCT03907852)TCR2 Therapeutics2019-04-15
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer (NCT03606486)University of Washington2018-11-16
Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) (NCT02756130)Jonsson Comprehensive Cancer Center2018-08-01
Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02316834)M.D. Anderson Cancer Center2015-06-02
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian (NCT02208375)M.D. Anderson Cancer Center2014-11-11
Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC (NCT04846933)Turku University Hospital2012-02-01

Track High Grade Ovarian Serous Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.